TCM Pharma ApS: Financial statements 2023
CVR: 39022508
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TCM Pharma ApS (CVR 39022508) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 223,313 and a net result of DKK 136,379 compared with DKK -163,358 the year before. That is an increase of 40.5% compared with the year before. Equity in the 2023 report amounted to DKK 53,353. The solvency ratio was 10.6%.
- Gross Profit
- DKK 223,313
- Profit/Loss
- DKK 136,379
- Equity
- DKK 53,353
- Total Assets
- DKK 503,219
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 223 t. | 136 t. | 53 t. | 0 |
| 2022 | - | 159 t. | -163 t. | -283 t. | 0 |
| 2021 | - | 458 t. | 134 t. | -214 t. | - |
| 2020 | - | 67 t. | -276 t. | -348 t. | 0 |
| 2019 | - | -17 t. | -114 t. | -72 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
TCM Pharma ApS has published its annual report for 2022. Gross profit came to DKK 158,887, and the net result was DKK -163,358.
About TCM Pharma ApS
TCM Pharma ApS is a Danish company of the type Anpartsselskab based in Farsø, founded in 2017. The company is under bankruptcy. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Løgstørvej 80 ApS and S. Greenhouse ApS. The company is owned by A.T.L. Holding ApS. The company has 1 employee (2022). In 2023, the company reported a gross profit of DKK 223,313 and a net result of DKK 136,379 compared with DKK -163,358 the year before. Equity in the 2023 report amounted to DKK 53,353.